A carregar...
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
INTRODUCTION: Recent randomized trials have demonstrated the efficacy of ibrutinib-based therapy in the treatment of patients with CLL. In Alliance A041202, a higher than expected number of unexplained deaths were reported with front-line ibrutinib in a patient population aged at least 65 years comp...
Na minha lista:
| Publicado no: | Blood Lymphat Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473982/ https://ncbi.nlm.nih.gov/pubmed/32943973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S262592 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|